Pfizer vaccine
The FDA has announced that extra doses contained in Pfizer COVID-19 vaccine vials could expand America’s supply of the jab by up to 40%.
Vials of the US-based company’s vaccine were expected to contain only five doses, but pharmacists have found that each vial could provide up to seven.
The FDA yesterday assured pharmacists that the extra doses could be used, a change that would prevent the waste of leftover vaccine and significantly increase the US’ supply of the jab.
![[column] Toekomst tijdschriften glanst als nooit tevoren](https://www.pharmamarketeer.nl/wp-content/uploads/2024/12/happy-couple-in-t-shirts-reading-newspaper-while-h-2024-11-10-00-13-23-utc-1-80x60.jpg)
![[column] MarketingAffairs 17: Marketing als oplossing](https://www.pharmamarketeer.nl/wp-content/uploads/2024/12/asian-seo-manager-writing-on-glass-with-illustrati-2024-11-17-23-11-51-utc-1-80x60.jpg)
